Glasson P, Leski M, Favre H
Schweiz Med Wochenschr. 1981 Aug 22;111(34):1232-8.
Continuous ambulatory peritoneal dialysis for end-stage renal failure was first described in 1976. The purpose of the present study was to establish the value of this method in a group of eight patients with various renal diseases who were controlled monthly for one year. Main benefit was correction of anemia, better control of calcium and phosphate, and excellent blood pressure control. Hyperlipoproteinemia was observed in all patients, as was an increase in plasma renin activity and aldosterone. Thyroid values were in the low normal range. A low incidence of peritonitis was observed and cases of peritonitis were treated on an ambulatory basis. The results suggest that more patients could be included in this new treatment for end-stage renal disease.
持续性非卧床腹膜透析治疗终末期肾衰竭于1976年首次被描述。本研究的目的是确定该方法在一组八名患有各种肾脏疾病的患者中的价值,这些患者每月接受一次检查,为期一年。主要益处包括纠正贫血、更好地控制钙和磷以及出色的血压控制。所有患者均观察到高脂蛋白血症,同时血浆肾素活性和醛固酮增加。甲状腺指标处于低正常范围。观察到腹膜炎的发生率较低,且腹膜炎病例在门诊进行治疗。结果表明,更多患者可纳入这种终末期肾病的新治疗方法。